Verastem

Verastem

Verastem

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
Raised
$68M
Follow us
Alexa global traffic share
11 Nov 2011
$20,000,000
Venture capital (Series C)
14 Jul 2011
16 Nov 2010
$16,000,000
Venture capital (Series A)